Webinar on June 16th: Leaving No One Behind
Hepatitis elimination efforts must include everyone and focus on improving disparities in burden and access to care. Join our next webinar with US National Institutes of Health exploring research on tailoring hepatitis prevention, testing, and treatment to diverse communities.
Country dashboards
Select a country to see key HBV and HCV related data or check out the data dashboard homepage
Hepatitis C Elimination Tool
The online interactive tool supports budget-based planning by allowing countries to estimate the hepatitis C testing and treatment volumes needed for elimination and the associated costs. The tool is available to countries free-of-charge and technical assistance is available to support partners in using the tool.
Latest
@GlobalHep Call for #abstracts! The abstract portal for #COLDA is open. Present your data on the #liver disease in Africa to the experts! Deadline: 1 July 2022 Submit here > https://t.co/M25Vi0B6Du https://t.co/3G6Hy7dxDr
@GlobalHep @Memphis @NAkufoAddo @FCBarcelona Help us eliminate hepatitis in Ghana @GlobalHep
@GlobalHep The abstract deadline for #COLDA2022 has been extended! The portal is open until Friday, 1 July 2022 at 23:59 SAST/EET/CEST Take advantage of the extension & submit your abstract now. Submit here > https://t.co/M25Vi0B6Du #LiverDisease #Hepatology #HBV #HCV #COVID19 https://t.co/Hv0XQuOToR
@GlobalHep Thank you Dr. @ponnivp for important guidance on designing community-centered #hepatitis outreach programs & the great example working with the African Services Committee in NYC @NIMHD https://t.co/HmzcnyMXWn
RT @HepAidOrg @HepAidOrg is thankful to @CDCgov and @GlobalHep for the capacity building training with our team on #HepatitisB Birth-dose communication. @Hep_Alliance @MinofHealthUG https://t.co/XzZ2g1s8kD
@GlobalHep Since @HarvardCHLPI & @NVHR1 launched Hepatitis C: State of Medicaid Access in 2017, US state #Medicaid programs have removed many restrictions to #HCV treatment. Yet barriers remain. Join them June 22 @ 4pm ET to hear about the next phase of the project: https://t.co/uxASS3LaUH https://t.co/BVYuAPZ6Sn
@GlobalHep "We ask all clinicians & researchers active in the care of HCV in pregnancy to contribute data on DAA exposures in pregnancy to the TiP-HepC registry" The TiP-HepC registry is open for case submission! Read the full correspondence in @LancetGastroHep: https://t.co/5WPKFhcQgx
@GlobalHep Tomorrow! Webinar: "Leaving No One Behind: Culture and Context Count in Tailoring Hepatitis Interventions" Talks include- 🔎community-based elimination programs 🔎integration of HCV screening in primary care 🔎innovative patient education Register: https://t.co/ibgbP1iiQj @NIMHD https://t.co/lsYTNtnSX5
RT @Pwadex12 Partnership working @HepatitisCTrust & @Aspire_Recovery eliminating #hepC in Doncaster .. All the staff doing amazing work 💜 #gettested #saveinglives #WEhaveacure #harmreduction https://t.co/G3dKQPmpiw
RT @IDinATL An outbreak of hepatitis A is taking over Tripoli and is now spreading to other areas of Lebanon! Vaccination is approved for pre-exposure AND post-exposure prophylaxis but the vaccine is virtually unavailable in Lebanon because of the economic crisis! We need help!!!! @WHO
@GlobalHep Don't forget the next @NIH "Moving from Hepatitis Discovery to Elimination" webinar co-hosted with @NIMHD is Thursday, June 16th! Topic: "Leaving No One Behind: Culture and Context Count in Tailoring Hepatitis Interventions" Register here: https://t.co/ibgbP1iiQj See you there! https://t.co/31aY49gsky
@GlobalHep JUST PUBLISHED in @LancetGastroHep: our new correspondence w/ @cdchep announcing the TiP-HepC registry. "To achieve HCV cure for all...establishing the safety of DAAs in pregnancy is paramount" Read here: https://t.co/5WPKFhcQgx @AASLDtweets @TFGH @TatyanaKushner @NO_hep https://t.co/aC2QlvUO63